Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 September 2021 | Story Lacea Loader | Photo Supplied
Mr David Noko, newly appointed Chairperson of the UFS Council.

During its third scheduled meeting for the year that took place virtually on 17 September 2021, the Council of the University of the Free State (UFS) appointed Mr David Noko as Chairperson for a term of four years, as from 1 October 2021.

Mr Noko, who was Deputy Chairperson of the Council, will take over the Chairpersonship from Dr Willem Louw, whose term will come to an end on 30 September 2021.
 
“On behalf of the Council, I congratulate Mr Noko and wish him all the best during his term of leading the Council of the UFS. With the skills and competence available in the Council, complemented by Prof Francis Petersen, Rector and Vice-Chancellor, and his team, he has access to a formidable group of individuals to support him in the execution of this very important role,” said Dr Louw during the meeting. 
 
“I am humbled and honoured for the opportunity and thank the Council for their confidence and trust in me. Since serving on the Council, I have become an ambassador of the University of the Free State, talking to many stakeholders about the institution and how much it should be supported. I am here to serve and look forward to doing so in a professional and dignified manner, together with everyone on the Council and with the leadership of the university,” said Mr Noko.
 
Mr Noko is well-known and respected internationally as a business leader. He has a National Higher Diploma in Mechanical Engineering from the Technikon Witwatersrand (now the University of Johannesburg), a Management Development Programme (MDP) Certificate from the University of the Witwatersrand, and a Postgraduate Diploma in Company Directorships from the Graduate Institute of Management and Technology. He also completed a master’s degree in Business Administration at the Heriot-Watt University and a Senior Executive Programme at the London Business School.
 
Before retiring from the corporate world in 2019, Mr Noko was the Executive Vice-President of AngloGold Ashanti, where he was responsible for the company’s global Sustainable Development and Government Relations portfolios. His career began at the General Electric Company (GEC) before moving to South African Breweries in 1987, and then to Pepsi-Cola International in 1994, where he gained extensive international exposure and global experience.
 
In 1999, Mr Noko was appointed as Chief Executive Officer (CEO) of Air Chefs (Pty) Ltd in South Africa, before joining De Beers in 2002. In 2006, he was appointed Managing Director and CEO of De Beers Consolidated Mines Limited (DBCM), and in 2010 he founded his own company, CelaCorp (Pty) Ltd. He also founded ESG Advisory (Pty) Ltd, a company providing advisory services to corporates relating to environment, social and governance matters, mostly focusing on mining companies.
 
He is a member of the Institute of Directors SA and served on the boards of Royal Bafokeng Platinum Limited, Harmony Gold (Deputy Chairman), AstraPak Ltd, and PlatiStone Holdings (Chairman). He is currently a board director of African Rainbow Minerals Ltd, Tongaat Hulett Ltd, and Aveng Moolmans (Pty) Ltd.

The Council also thanked Dr Louw for his service and for the impeccable leadership he displayed during the time he served.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept